Android app on Google Play

Ascendiant Capital Starts Solta Medical (SLTM) at Buy

July 5, 2012 12:28 PM EDT Send to a Friend
Get Alerts SLTM Hot Sheet
Price: $2.92 --0%

Rating Summary:
    3 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 4 | New: 7
Trade SLTM Now!
Join SI Premium – FREE
Ascendiant Capital initiates coverage on Solta Medical (NASDAQ: SLTM) with a Buy. PT $3.50.

The firm said acquisitions create a stronger company, it has an attractive recurring revenue model, the aesthetic market is expected to experience steady growth, non-invasive fat reduction is a fast growing segment, and valuation is attractive.

"We believe that Management has demonstrated good discipline, acquiring products that have an established brand name, a high gross margin with a disposable component, and a good fit for its existing sales force that is focused on dermatologists and plastic surgeons. As a result, we believe that SLTM represents one of the more attractive investments in this segment," the analyst said.

For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.

Shares of Solta Medical closed at $2.98 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment